The Gairdner Foundation recognizes the achievements of researchers who have made breakthrough discoveries in biomedical science.
betterplace gives you direct and focused ways to have impact on causes you deeply care about -- turning your individual efforts into powerful collective action for social change.
DNAstack develops software to save lives and improve health by accelerating the world’s ability to understand the genome.
The Ted Rogers Centre for Heart Research seeks to reduce heart failure across all age groups. It boasts three distinguished partners: The Hospital for Sick Children (SickKids), University Health Network (UHN) and the University of Toronto (U of T).
With members spanning many top Canadian universities, SOSCIP is a research and development consortium. It provides advanced computing resources to researchers in disciplines like energy, the environment and manufacturing.
Powering professionals across a variety of scientific and technical fields, SciNet gives researchers the tools they need inside a supercomputer centre. SciNet is also a partner in the Compute/Calcul Canada national advanced research computing platform.
Compute/Calcul Ontario is solving large global challenges with powerful computers and networks. It acts as a regional resource hub.
Ryerson’s Faculty of Science gives students the skills they need for careers in fields like physics, chemistry, biology, computer science and mathematics. It’s at the forefront of scientific discovery in Toronto.
JLABS @ Toronto is the first to open outside of the US. It houses lab space and state-of-the-art equipment, plus experts and early-stage companies in the fields of pharmaceuticals, medical devices, consumer and digital health programs.
The University of Toronto’s Faculty of Medicine is dedicated to tackling global medical problems through research and innovation.
Sheba Microsystems develops high-end MEMS sensors and actuators for use in tech products like miniature cameras — where they perform functions like autofocus. It also creates 3D touchscreen technology.
3DS is a personalized medicine company with a software platform based on the three-dimensional analysis of chromosomal signatures. The technology measures the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity in several cancers and Alzheimer's disease.
XOR Labs Toronto commercializes technologies developed by the University Health Network that have either been clinically validated or have promising research results. It focuses on the fields of organ transplantation and diseased organ treatment.
MaRS Innovation is an early-stage seed investment fund for companies and technologies that stem from its members – which span universities, hospitals and research institutes.
Medicine by Design brings together more than 100 high-calibre researchers in a globally competitive hub focused on regenerative medicine and cell therapy. We generate and utilize leading-edge technological, experimental and computational approaches to make paradigm-shifting discoveries.
CIFAR is finding the root causes of human diseases, developing technology to improve quality of life, bridging the divide between rich and poor nations, and meeting our future energy needs.
Woodland Biofuels creates cellulosic ethanol from wood chips and other types of forestry and agricultural waste at half the cost of producing the gasoline its biofuel replaces.
Transition Therapeutics is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets.
Triphase in-licenses clinically enabled oncology assets with high-value potential and develops them in a shared risk model to proof-of-concept, then out-licenses or sells the product to create value.
University Health Network includes Toronto General and Toronto Western Hospitals, Princess Margaret Cancer Centre, and Toronto Rehabilitation Institute.
The UHN office of Technology Development & Commercialization (TDC) works with research scientists and clinicians at the University Health Network to create new intellectual property and advance it towards innovative commercial applications.
The Structural Genomics Consortium is a public-private partnership to promote the development of new medicines by carrying out basic science of relevance to drug discovery.
Sigma Analysis & Management Ltd. is a portfolio management firm, specializing in alternative products and portfolio architecture for institutional investors.
RBC provides tailor-made, comprehensive banking and investment solutions to our clients.
Proteocyte Diagnostics is a Canadian molecular diagnostics company founded in August 2011.
Opalux is the pioneer of a broad range of colour changing materials.
The Ontario Institute for Cancer Research is an innovative cancer research and development institute dedicated to prevention, early detection, diagnosis and treatment of cancer.
Ontario Genomics connects companies, researchers and policy-makers to support the early stages of genomics technologies’ move from the lab to solve real-world problems in the clinic and in industry.
The National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) supports small and medium-sized enterprises in Canada grow stronger, grow faster, grow bigger through innovation and technology.
The National Angel Capital Organization (NACO) accelerates a thriving, early-stage investing ecosystem in Canada by connecting individuals, groups and other partners that support angel-stage investing.